How Otter Tail OTTR prepares for market disruptions Q4 2025 Profit Disappoints The governance signals in Zhihu Inc ZH earnings quality Zhihu Inc Misses Estimates as Loss Widens Sharply OVID Ovid Therapeutics swings to profit with 1181 revenue jump defying biotech sector headwinds in Q4 2025 Escalade Inc ESCA Delivers Robust Q1 2026 Earnings Driven by Margin Expansion and Acquisitions